Insider · CIK 0001425052

DHILLON PUNIT

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001425052

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-07	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+1.09M sh	—	—	1,419,823
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+125K sh	—	—	125,000
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−250K sh	—	—	0
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−36K sh	—	—	0
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−9,013 sh	—	—	0
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−650K sh	—	—	0
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+36K sh	—	—	36,000
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−12.4K sh	—	—	0
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+650K sh	—	—	650,000
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−21.6K sh	—	—	0
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−125K sh	—	—	0
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+21.6K sh	—	—	21,586
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+9,013 sh	—	—	9,013
2026-03-31	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+12.4K sh	—	—	12,360
2026-02-06	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+280K sh	—	—	280,000
2025-02-24	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2024-11-18	SKYESkye Bioscience, Inc.S Sale	Director, Chief Executive Officer	SSale	−82.5K sh	$4.99	−$412K	329,823
2024-11-15	SKYESkye Bioscience, Inc.S Sale	Director, Chief Executive Officer	SSale	−364 sh	$5.55	−$2,020.2	412,369
2024-10-28	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+650K sh	—	—	650,000
2024-08-26	SKYESkye Bioscience, Inc.J Other	Director, Chief Executive Officer	JOther	+15.7K sh	—	—	412,733
2024-02-29	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+125K sh	—	—	125,000
2024-02-29	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+125K sh	—	—	125,000
2024-02-29	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	397,006
2024-02-29	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	397,006
2023-11-06	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+194K sh	—	—	297,006
2023-11-06	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+21.6K sh	—	—	30,599
2023-08-29	SKYESkye Bioscience, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+881K sh	$0.02	+$16.5K	41,554,828
2023-08-29	SKYESkye Bioscience, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+881K sh	$0.02	+$16.5K	25,683,957
2023-08-28	SKYESkye Bioscience, Inc.L Small Acquisition	Director, Chief Executive Officer	LSmall Acquisition	+110K sh	$0.02	+$1,881	24,802,957
2023-08-28	SKYESkye Bioscience, Inc.L Small Acquisition	Director, Chief Executive Officer	LSmall Acquisition	+110K sh	$0.02	+$1,881	40,673,828
2023-08-25	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+20.3M sh	—	—	40,554,828
2023-08-25	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+2.25M sh	—	—	2,253,046
2023-08-25	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+2.25M sh	—	—	2,253,046
2023-08-25	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+20.3M sh	—	—	24,683,957
2023-08-23	SKYESkye Bioscience, Inc.L Small Acquisition	Director, Chief Executive Officer	LSmall Acquisition	+9,000 sh	$0.01	+$106.2	24,692,957
2023-08-23	SKYESkye Bioscience, Inc.L Small Acquisition	Director, Chief Executive Officer	LSmall Acquisition	+9,000 sh	$0.01	+$106.2	40,563,828
2022-11-10	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+2.34M sh	—	—	2,335,721
2022-11-10	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+1.41M sh	—	—	4,406,543
2022-11-10	Arch Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2022-11-10	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+293K sh	—	—	292,500
2022-11-10	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+488K sh	—	—	487,500
2022-11-10	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+390K sh	—	—	390,000
2022-11-10	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+390K sh	—	—	390,000
2021-12-14	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+3.09M sh	—	—	3,090,000
2021-12-14	SKYESkye Bioscience, Inc.A Award	Director, Chief Executive Officer	AAward	+2M sh	—	—	3,000,000
2021-09-27	Arch Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2021-09-27	Arch Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2020-08-07	SKYESkye Bioscience, Inc. · Employee Option Grant (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+9M sh	—	—	9,200,000
2020-08-07	SKYESkye Bioscience, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1M sh	$100000.00	+$100B	1,000,000

Recent filings

Accepted (ET)
Aug 74
DHILLON PUNIT0001628280-26-054941
SEC(opens sec.gov)
Apr 24
DHILLON PUNIT0001628280-26-023337
SEC(opens sec.gov)
Feb 94
DHILLON PUNIT0001628280-26-006618
SEC(opens sec.gov)
Feb 264
DHILLON PUNIT0001516551-25-000010
SEC(opens sec.gov)
Nov 194
DHILLON PUNIT0001516551-24-000116
SEC(opens sec.gov)
Oct 304
DHILLON PUNIT0001516551-24-000101
SEC(opens sec.gov)

Companies

Address

11250 EL CAMINO REAL, SUITE 100 C/O SKYE BIOSCIENCE, INC.

SAN DIEGO, CA, 92130